Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2025-12-17 @ 5:53 AM
Study NCT ID:
NCT05921006
Status:
None
Last Update Posted:
2023-07-06 00:00:00
First Post:
2023-06-15 00:00:00
Brief Title:
Ascending Single-Dose and Multiple-Dose Study to Evaluate RJ4287 in Healthy Subjects
Sponsor:
Nanjing Ruijie Pharma Co Ltd
Organization:
Nanjing Ruijie Pharma Co., Ltd.
Study Overview
Official Title:
A Phase 1, Double-blind, Randomized, Placebo-controlled, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-effect of Single and Multiple Oral Doses of RJ4287 in Healthy Volunteers
Status:
None
Status Verified Date:
2023-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Randomized Study of RJ4287 Drug to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-effect of Single and Multiple Doses in Healthy Volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None